Executive Summary
This digest covers July 2, 2026, a session dominated by corporate restructuring, M&A, and regulatory closures in Indian and US markets. A clear sector theme is consolidation in the Indian eye care and manufacturing sectors, with Dr. Agarwal's and GSP Crop Science advancing major schemes.
However, the most critical development is the Sysco/Jetro Restaurant Depot merger, a high-value US deal with substantial regulatory and integration risks. Period-over-period data reveals mixed signals: while Primo Chemicals' acquisition target, Flow Tech, shows strong revenue growth of 24.2%, BLS E-Services' acquisition ATPL saw a 5% revenue decline. Insider and promoter activity was entirely neutral, consisting of inter-se transfers and personal investments with no material market signal.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from June 25, 2026.
Investment Signals (11)
- Sysco/Jetro Restaurant Depot (JRD) (BULLISH)▲
Merger creates a foodservice powerhouse with pro-forma scale. JRD/Sysco equityholders will hold 16%/84% of combined entity, a significant value transfer allowing exposure to JRD's high-growth cash-and-carry model.
- BASF India ↓ (BULLISH)▲
Planned demerger of its agricultural solutions business (FY26 sales INR1,944 Cr, PBT INR254 Cr, ~25% of sales from new products since 2022) unlocks value. Shareholders receive 1:1 share in new listed entity (BASIL) by March 2027.
- BPCL / IBV Brasil (BULLISH)▲
Increased stake to 100% for INR2,312 Cr gives full control over Brazilian oil & gas concessions, directly contributing to India's energy security. Target has had nil turnover for 3 years, making this a long-term strategic asset play.
- Dr. Agarwal's Health Care ↓ (BULLISH)▲
Shareholders overwhelmingly approved amalgamation with Dr. Agarwal's Eye Hospital (99.97% in favor), creating a single listed entity. This simplifies structure and likely improves operational efficiency.
- Primo Chemicals ↓ (BULLISH)▲
Acquiring remaining 51% of Flow Tech at INR1,418.20/share. Flow Tech's revenue jumped 24.2% in FY26 to INR34,166 lakh, and PAT surged from INR254.58 lakh to INR979.58 lakh, demonstrating strong operational turnaround.
- BLS E-Services ↓ (BEARISH)▲
Completed acquisition of Atyati Technologies for INR156.82 Cr. However, Atyati's revenue declined 5% YoY (FY26: INR375.8 Cr vs INR395.6 Cr), signaling potential execution challenges or competition.
- Mobility Global (MBGL)▲
Completed spin-off from S&P Global, beginning trading on NYSE. Risks are high as an independent entity with no standalone track record, significant debt, and exposure to auto industry volatility. Insider actions limited to leadership appointments. [BEARISH/NITIAL NEUTRAL]
- StableCoinX ↓ (BEARISH)▲
Going-concern qualification in audit with $0 revenue and negative equity. 180-day deadline to close SPAC merger with TLGY Acquisition Corp extended to July 21, 2026. Failure to close threatens viability.
- RenovoRx (RNXT) (BEARISH)▲
Received second 180-day Nasdaq extension to Dec 28, 2026 to meet $1 bid price. Ongoing failure poses delisting risk.
- Everflow Eastern Partners ↓ (BEARISH)▲
Tender offer for units was rejected by holders, with only 11.1% of the maximum tendered. This signals lack of holder confidence or dissatisfaction with the $1.35/unit price.
-
Adopted new articles for a 30-month extension to find a business combination. While standard for SPACs, this underscores the difficulty of closing a deal in the current market. [NEUTRAL/BEARISH]
Risk Flags (9)
- SKIL Infrastructure / Insolvency↓ [HIGH RISK]▼
CoC meeting held with no resolution plan update. Company remains under CIRP since Feb 2024. Failure to file or approve a plan could lead to liquidation.
- StableCoinX / Going Concern↓ [HIGH RISK]▼
Auditor raised substantial doubt about the company's ability to continue. Only capital for ~12 months without a successful SPAC merger.
- RenovoRx / Nasdaq Delisting↓ [HIGH RISK]▼
Failed to comply with $1 bid price by June 30, 2026. Relies on a second 180-day extension. If failed by Dec 28, 2026, delisting likely.
- BLS E-Services (ATPL acquisition)↓ [MEDIUM RISK]▼
Purchase consideration of INR156.82 Cr comes as the target's revenue declines 5% YoY. Integration and unplanned restructuring costs could weigh on parent margins.
- Sysco / Jetro Deal [MEDIUM RISK]▼
Termination fee of $1.164 billion is a huge contingent liability if the deal fails regulatory or HSR clearance. Equity dilution for existing Sysco holders is significant (84% post).
- DS Kulkarni Developers / Acquisition↓ [MEDIUM RISK]▼
Board meeting to acquire 100% stake in Moonbrick Realty with no disclosed financial terms or valuation. Opacity around the deal could lead to minority pushback.
- Devika Proteins / Insolvency↓ [HIGH RISK]▼
Former promoters and public shareholders saw their holdings cancelled or proportionately reduced. Existing investors face significant capital loss.
- Dr. Agarwal's Eye Hospital (Minority Opposition) [MEDIUM RISK]▼
At the shareholder meeting, public shareholders voted 48.10% against the scheme. While it passed, strong minority dissent signals potential future litigation or governance concerns.
- Mobility Global / Cost Infrastructure↓ [MEDIUM RISK]▼
Filing warns of significant costs to create independent public company infrastructure. No historical standalone profitability data to assess future earnings power.
Opportunities (8)
- BPCL / IBV Brasil (OPPORTUNITY)◆
Full control of Brazilian oil & gas assets with zero current revenue is a pure-play bet on future production and commodity price recovery. Cash consideration paid suggests balance sheet strength.
- Primo Chemicals / Flow Tech↓ (OPPORTUNITY)◆
Acquiring a company with 24.2% revenue growth and a 284% PAT increase presents a high-growth bolt-on at a likely premium but with tangible results. Forward guidance from Primo could see upward revision.
- BASF India / Demerger↓ (OPPORTUNITY)◆
Shareholders receive BASIL shares pro-rata by March 2027, potentially unlocking value from the high-growth agri-solutions business. Trading at a sum-of-parts discount.
- Bikaji Foods / JBDSPL↓ (OPPORTUNITY)◆
Acquired 74% of JBDSPL for INR1,48,000 only, a negligible price. Target's turnover jumped from INR0.04 Cr to INR19.81 Cr in one year. Extremely accretive acquisition with minimal cash outlay.
- GSP Crop Science / Amalgamation↓ (OPPORTUNITY)◆
Streamlining structure by merging two wholly-owned subs. No cash or shares issued, leading to cost savings and improved operational control. Patient investors benefit from enhanced margins over time.
- Lenskart / JV with Mingfeng↓ (OPPORTUNITY)◆
JV to manufacture metal frames reduces import dependence and secures supply chain. Strengthens vertical integration in a high-growth eyewear market.
- TVS Holdings / HCIFPL Rights Issue↓ (OPPORTUNITY)◆
Invested INR176.38 Cr to strengthen HCIFPL, which has steady 3-year revenue growth and FY26 PAT of INR132.24 Cr. Shows commitment to expanding NBFC operations.
- Inventurus / TruBridge Acquisition↓ (OPPORTUNITY)◆
Reduced financing from $670M to $635M signals disciplined leverage management. Deal on track to close, offering a specialty healthcare IT play.
Sector Themes (6)
- Rapid Consolidation in Indian Eye Care & Agri-inputs◆
Dr. Agarwal's Health Care/Eye Hospital amalgamation and GSP Crop Science's internal restructuring show a clear pattern of businesses simplifying structures to unlock value and achieve scale. Benefits are typically operational (cost synergies) rather than financial (no new cash).
- Indian Promoter-Led M&A Dominates◆
A vast majority of M&A filings are inter-se promoter transfers (Robust Hotels, Gujarat Themis) or acquisitions of wholly-owned/associate companies (Primo, DS Kulkarni). This suggests a focus on ownership consolidation and internal reorganization rather than third-party market expansion.
- Distress at the Bottom: CIRP & Delisting Spreads◆
SKIL Infrastructure and Devika Proteins highlight ongoing stress in Indian infrastructure and protein processing sectors. Meanwhile, US micro-caps (StableCoinX, RenovoRx) face existential going-concern and delisting risks, pointing to a weak small-cap/high-risk cohort.
- Energy Security Driving Indian Outbound M&A◆
BPCL's Brazilian asset complete acquisition is a trend-setter for Indian state-owned/PSUs looking to secure upstream oil & gas assets. Zero revenue for 3 years underscores a long-term strategic vs. financial rationale.
- Weak SPAC Market Continues◆
Ares Acquisition Corp III extended its deadline and Everflow Eastern Partners saw a thumping rejection of its tender offer. The SPAC pathway is proving difficult to exit, with few attractive targets and lack of investor confidence.
- Business Correspondent (BC) Sector Heat◆
BLS E-Services paid a significant cash deal for a BC player with declining revenue. This may signal a broader race for scale in the financial inclusion/last-mile banking sector, potentially overpaying for assets.
Watch List (8)
- Sysco / Jetro Restaurant Depot👁
Await HSR Act clearance. Any regulatory condition requiring asset sales or structural remedy could jeopardize the merger. Watch for Q3 earnings call for integration synergy updates.
-
Final NCLT sanction expected in Aug/Sep 2026. Watch for any shareholder litigation following significant minority opposition at Dr. Agarwal's Eye Hospital.
-
Outside date July 21, 2026. Failure to close is terminal. Monitor for any extension announcements or termination.
- RenovoRx (RNXT)👁
Must maintain $1 bid for 10 consecutive days by Dec 28, 2026. Quarterly results (est. Nov 2026) and any reverse stock split announcement will be critical.
- BPCL / IBV Brasil👁
First production update from Brazilian concessions. Annual report FY27 will show initial contribution to equity oil.
-
Natural catalyst is the postal ballot results for the acquisition and new director appointments. Forward guidance for Flow Tech post-acquisition will be key.
-
NCLT-convened shareholder meeting on July 30, 2026. Outcome may provide clues on the company's future direction post-insolvency.
-
Quarterly results to show impact of ATPL consolidation (declining revenue). Watch for restructuring charges and margin impact.
Filing Analyses
(50)
02-07-2026
Arun Kumar Saraf, a promoter of Robust Hotels Limited, has acquired 20,26,520 shares (11.72% of the company's total share capital) via a gift transfer from his immediate relative and fellow promoter, Mrs. Ratna Saraf, on June 30, 2026. The transaction is an inter-se transfer among promoters, exempted under SEBI (SAST) Regulations, and does not change the aggregate promoter and promoter group shareholding. Post-transaction, Mr. Saraf's individual holding increased from 0.08% to 11.80%, while Mrs. Saraf's holding decreased from 23.44% to 11.72%.
- · The transfer was executed as a gift on June 30, 2026.
- · The aggregate promoter and promoter group holding remains unchanged after the transaction.
- · The transaction qualifies for exemption under Regulation 10(1)(a)(i) of the SEBI Takeover Code as an inter-se transfer among immediate relatives.
02-07-2026
Promoter Sachin D. Patel proposes to acquire up to 5,25,000 equity shares (0.50% of share capital) of Gujarat Themis Biosyn Limited from Pharmaceutical Business Group (India) Limited, an inter-se transfer among the promoter group, at ₹395.75 per share (total consideration up to ₹20 Crore). The acquisition will increase his holding from 2.29% to 2.77%, while the seller's stake will decrease from 47.02% to 46.54%.
- · Proposed acquisition date window: 08.07.2026 to 14.07.2026
- · Acquisition price: ₹395.75 per equity share
- · 60-day VWAP: ₹376.60 per equity share
- · Exemption claimed under Regulation 10(1)(a)(ii) of SEBI (SAST) Regulations
- · Acquirer declares price will not exceed 125% of the 60-day VWAP
02-07-2026
North Eastern Carrying Corporation Limited disclosed that its promoter and director, Mr. Utkarsh Jain, acquired a 12% stake (3,356 equity shares) in SG Green Logistics Private Limited for a cash consideration of ₹35.99 Crores. The company emphasised that this acquisition is a personal investment by Mr. Jain and has no material impact on NECC's operations, management, or shareholding structure. SG Green Logistics, incorporated in April 2022, has shown consistent revenue growth from ₹49.57 Crore (FY2023-24) to ₹83.37 Crore (FY2025-26).
- · SG Green Logistics was incorporated on April 21, 2022, in India for fleet carriage and goods transportation.
- · The acquisition is a cash consideration transaction and does not fall within related party transaction.
- · No governmental or regulatory approvals were required for the acquisition.
- · FY2025-26 revenue of SG Green Logistics stood at ₹83.37 Crore, up from ₹64.16 Crore in FY2024-25 and ₹49.57 Crore in FY2023-24.
02-07-2026
Devika Proteins Ltd (now Dharti Proteins Ltd) has completed a corporate insolvency resolution process (CIRP), resulting in a change of ISIN from INE248C01013 to INE248C01021. The resolution plan involved the cancellation of the entire shareholding of the erstwhile promoters and promoter group, a proportionate reduction in existing public shareholders' holdings, and a preferential allotment of equity shares to the new promoter group and secured financial creditor. The new ISIN was activated by NSDL on June 30, 2026, and by CDSL on July 1, 2026.
- · The company name changed from Devika Proteins Ltd to Dharti Proteins Ltd as part of the resolution.
- · Old ISIN: INE248C01013; New ISIN: INE248C01021.
- · The resolution plan included capital reduction and preferential allotment of shares to the successful resolution applicant and its group, as well as to the secured financial creditor.
- · NSDL activated the new ISIN on June 30, 2026; CDSL activated it on July 1, 2026.
- · Registrar for the ISIN is System Support Services.
02-07-2026
SKIL Infrastructure Ltd, currently under Corporate Insolvency Resolution Process (CIRP), held its 7th Committee of Creditors (CoC) meeting on July 1, 2026, via virtual mode. The meeting lasted from 5:00 PM to 6:30 PM. No financial results, resolution plan updates, or period-over-period comparisons were disclosed in this filing.
- · Company is under CIRP per NCLT Mumbai order dated February 1, 2024.
- · Resolution Professional is Purusottam Behera (IBBI Reg. No. IBBI/IPA-002/IP-N00940/2019-20/12993).
- · Meeting was conducted via audio-visual virtual mode.
- · No resolution plan or financial details were provided in this intimation.
02-07-2026
BASF India Limited held an NCLT-convened equity shareholders meeting on June 24, 2026, to seek approval for the demerger of its agricultural solutions business into a separate listed entity, BASF Agricultural Solutions India Limited (BASIL). The agricultural solutions business reported sales of INR1,944 crore and profit before tax of INR254 crore in FY2025-26, with strong innovation momentum (12 new products since 2022 contributing ~25% of sales). Shareholders will receive one share of BASIL for every share held in BASF India Limited, with allotment expected by March 2027 and subsequent listing on BSE and NSE. The meeting transcript was filed with stock exchanges on July 2, 2026.
- · The demerger scheme received no-objection letters from SEBI and stock exchanges.
- · Shareholders will receive one share of BASIL for each share held in BASF India Limited.
- · Allotment of BASIL shares expected by March 2027, followed by listing on BSE and NSE.
- · The meeting was conducted via video conferencing; physical attendance and proxies were dispensed with.
- · Remote e-voting was facilitated by NSDL; the scrutinizer was Mr. Hemant Shetye.
- · Notice of the meeting was sent electronically to shareholders with registered email addresses as of May 22, 2026.
- · Advertisements were published in Business Standard (English) and Lok Satta (Marathi) on May 23, 2026.
- · Quorum was satisfied with more than 30 members present.
- · The agricultural solutions business will implement its own ERP system post-demerger.
02-07-2026
StableCoinX Inc. filed an 8-K with audited financial statements for the period July 7, 2025 (inception) through December 31, 2025, reporting $0 in revenue and total assets, a net loss of $48,563, and negative stockholder's deficit of ($48,563). The company has a pending business combination with TLGY Acquisition Corporation and StablecoinX Assets Inc., with an extended outside date of July 21, 2026. However, the auditor's report includes a going concern qualification, noting substantial doubt about the company's ability to continue if it cannot complete the SPAC merger or raise additional funds within one year.
- · The company was incorporated on July 7, 2025, and its fiscal year ends December 31.
- · As of December 31, 2025, the company had 1 share of Class B common stock issued and outstanding and zero shares of Class A common stock.
- · Total operating expenses for the period were $48,563, all classified as general and administrative.
- · Accrued expenses of $18,900 and accrued expenses - related party of $29,663 comprised total liabilities.
- · The Business Combination Agreement has been amended twice to extend the outside date, currently set at July 21, 2026.
- · SC Assets' Decentralized Verifier Node (DVN) went live in November 2025; a subsequent DVN Services Agreement with Ethena Opco Ltd. on April 14, 2026 provides for a service fee of 1 basis point on bridged volume.
- · SC Assets' Validator Services went live in October 2025 and relies on a perpetual non-exclusive royalty-free software license with Schulz von Jacob Ltd., which is owned by the CTO of SC Assets.
- · The company's auditor, WithumSmith+Brown, PC, has served as auditor since 2025.
- · No cash was held at beginning or end of the period; net cash from operating, investing, and financing activities was all $0.
- · The company has no revenue and no operating history prior to 2025.
02-07-2026
Ares Acquisition Corporation III adopted amended and restated memorandum and articles of association on June 29, 2026, effective the same day, to facilitate its business combination strategy. The amendments include provisions for a 30-month extended period to complete a business combination, working capital withdrawals from the trust account, and conversion rights for Class B shares. The company has authorized share capital of US$999,999 divided into 9 billion Class A ordinary shares, 900 million Class B ordinary shares, and 99.99 million preference shares.
- · The company is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
- · The business combination must involve target businesses with an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding amounts disbursed for working capital and deferred underwriting discounts).
- · The company has 24 months from the closing of its IPO to complete a business combination, with an automatic extension of up to 30 months if a letter of intent is entered into.
- · Working capital withdrawals from the trust account are limited to $500,000 per year, with only $250,000 (plus rollover of unused interest) available in the six-month period beginning 24 months after the IPO if a letter of intent has been executed.
- · The company may redeem public shares if a business combination is not completed within the required timeframe.
02-07-2026
Mobility Global Inc. completed its separation from S&P Global Inc., distributing 100% of shares to S&P Global stockholders on a one-for-one basis effective July 1, 2026, and began trading on the NYSE under the ticker 'MBGL'. Leadership, including CEO Bill Eager, CFO Matt Calderone, and Chairman Joe Hinrichs, highlighted the company's financial strength, trusted brands (CARFAX, automotiveMastermind, Polk Automotive Solutions, Market Scan), and century-long credibility. Risks remain high as the company now operates as an independent public company with no historical standalone performance, significant debt obligations, and exposure to cybersecurity, litigation, and macroeconomic volatility—all detailed in the forward-looking statement risk factors.
- · The distribution was based on a record date of June 15, 2026, with each S&P Global stockholder receiving one share of Mobility Global common stock per share held.
- · Fractional shares were not distributed; they will be sold in the open market and stockholders will receive a cash payment.
- · Mobility Global will incur significant costs to create the infrastructure necessary as an independent public company and may experience operational disruptions.
- · The company will have debt obligations that could restrict business flexibility and increase cost of debt funding.
- · The separation may not qualify as tax-free for U.S. federal income tax purposes, potentially leading to significant tax liabilities for S&P Global and/or its stockholders.
- · The company has no history of operating as an independent company, and its historical financial information is not necessarily representative of future results.
- · Risk factors include potential loss of key customer groups, failure to develop new products, cybersecurity threats, and intellectual property challenges.
- · A large number of shares may be eligible for future sale, which could depress the market price, and the stock may not be included in major indices like the S&P 500.
02-07-2026
S&P Global Inc. completed the separation of its Mobility division into an independent public company, Mobility Global Inc. (NYSE: MBGL), effective July 1, 2026. Stockholders received one share of Mobility Global for each S&P Global share held on the record date of June 15, 2026, with fractional shares sold for cash. The company expects to release recast financials on July 6, 2026, reflecting the spin-off, but no financial performance data for the current or prior period is provided in this filing.
- · The separation was completed on July 1, 2026, after 15 months of preparation.
- · Mobility Global common stock began regular-way trading on NYSE under ticker 'MBGL' on July 1, 2026.
- · Distribution of 100% of Mobility Global shares was made to S&P Global stockholders as of 12:01 a.m. New York City time on July 1, 2026.
- · Record date for the distribution was June 15, 2026.
- · Fractional shares were not distributed; instead, they will be sold in the open market with cash proceeds paid to stockholders.
- · S&P Global expects to issue a press release on July 6, 2026, providing recast financial information for full year 2025, the four quarters of 2025, and Q1 2026.
- · Financial advisors: Morgan Stanley, Goldman Sachs, Citigroup, Evercore. Legal advisors: Davis Polk & Wardwell and Baker McKenzie.
02-07-2026
Sysco is acquiring Jetro Restaurant Depot (JRD) and Warehouse Realty via a merger, with JRD and Warehouse Realty equityholders expected to hold approximately 16% and Sysco stockholders approximately 84% of the combined entity, Sysco Holdings. The transaction is subject to HSR Act clearance and other customary conditions, and Sysco could owe a termination fee of $1.164 billion under certain circumstances. Risks include potential failure to realize anticipated synergies, regulatory delays or conditions, and litigation, while existing Sysco stockholders will have a reduced ownership stake in the combined company.
- · The transaction is subject to HSR Act waiting period expiration or termination and other customary conditions.
- · Sysco could owe a termination fee of $1.164 billion under certain circumstances.
- · Post-closing, JRD and Warehouse Realty equityholders are expected to hold approximately 16% and Sysco stockholders approximately 84% of Sysco Holdings common stock.
- · Sysco stockholders will have reduced ownership and economic interest in Sysco Holdings compared to their current ownership of Sysco.
- · Jetro Restaurant Depot is privately held with limited publicly available information; its financial statements have not been subject to SEC review.
- · Completion of the transaction may trigger change-in-control provisions in certain Jetro Restaurant Depot agreements.
- · Sysco equityholders do not have appraisal rights in connection with the transaction.
- · Potential litigation could result in substantial costs, an injunction preventing completion, or damages.
- · Regulatory authorities may impose conditions that could delay, prevent, or increase costs of the transaction.
02-07-2026
Mr. Jitesh Kothari and Mr. Atul Ramshankar Jaiswal have launched an open offer to acquire up to 27,74,970 equity shares (25.57% of expanded voting capital) of Arco Leasing Ltd at ₹10 per share, for a maximum consideration of ₹2,77,49,700. The offer opens on July 2, 2026, following a series of regulatory filings and newspaper publications. No financial performance data is provided in this filing.
- · The open offer is made under SEBI (SAST) Regulations.
- · Public Announcement date: March 13, 2026; Detailed Public Statement published March 23, 2026.
- · Draft Letter of Offer dated April 1, 2026; Letter of Offer along with Form of Acceptance and Form SH-4 dated June 23, 2026.
- · Recommendations of the Committee of Independent Directors (IDC) dated June 30, 2026, published July 1, 2026.
- · Offer Opening Public Announcement and Corrigendum published on July 2, 2026 in Financial Express, Jansatta, and Pratahkal.
02-07-2026
Bikaji Foods International Limited has completed the acquisition of a 74% equity stake in Jai Barbareek Dev Snacks Private Limited (JBDSPL) for a cash consideration of ₹1,48,000, making JBDSPL a subsidiary effective July 2, 2026. The acquisition aims to accelerate business growth and enhance market presence in Chhattisgarh, leveraging JBDSPL's contract manufacturing capabilities for snacks and namkeen. JBDSPL reported a turnover of ₹19.81 Crore for FY 2024-25, a significant increase from ₹0.04 Crore in the prior year, though the business had not commenced in FY 2022-23.
- · JBDSPL was incorporated on May 20, 2022, and is based in Durg, Chhattisgarh.
- · The acquisition was approved by the Board on May 21, 2026.
- · JBDSPL had no business in FY 2022-23, negligible turnover of ₹0.04 Crore in FY 2023-24, and a sharp jump to ₹19.81 Crore in FY 2024-25.
- · The acquisition is a cash transaction and not a share swap.
- · JBDSPL will continue as a contract manufacturer for Bikaji Foods.
02-07-2026
DS Kulkarni Developers Ltd has scheduled a Board Meeting on July 7, 2026, to consider the acquisition of a 100% equity stake in Moonbrick Realty Private Limited and the appointment of CS Rishika Verma as Company Secretary & Compliance Officer. The filing does not disclose any financial terms, performance metrics, or prior-period comparisons, so no quantitative trends can be assessed.
- · Acquisition target: 100% equity stake in Moonbrick Realty Private Limited (CIN: U68100PN2026PTC252347), a Pune-based realty company.
- · Appointment of CS Rishika Verma (M.No. A66507) as Company Secretary & Compliance Officer.
- · Board meeting scheduled for July 7, 2026.
02-07-2026
Lenskart Solutions Limited's Board approved a Scheme of Amalgamation to merge two wholly-owned subsidiaries (Dealskart Online Services Private Limited and Lenskart Eyetech Private Limited) into itself, and also approved the incorporation of a joint venture company in India with Mingfeng Glassesworld Limited, China, to manufacture metal spectacle frames. The amalgamation is exempt from stock exchange no-objection, and the JV aims to strengthen manufacturing capabilities and reduce import dependence.
- · The Scheme of Amalgamation is under Sections 230-232 of the Companies Act, 2013.
- · Transferor Company No. 1 (Dealskart) provides O&M services to omni-channel stores.
- · Transferor Company No. 2 (Lenskart Eyetech) operates training centers for retail staff.
- · The JV with Mingfeng Glassesworld Limited is a strategic partnership to localize manufacturing.
- · Board meeting commenced at 02:30 PM IST and concluded at 03:44 PM IST on July 2, 2026.
02-07-2026
Chatha Foods Limited has been allotted 11,96,700 equity shares at ₹10 each in its subsidiary Allana CF Foods Private Limited via a rights issue subscription, increasing its stake to 69.79%. The subscription consideration was ₹1,19,67,000, and Allana CF Foods, incorporated in April 2025, has no current turnover as it focuses on ready-to-eat and ready-to-cook products. The transaction is at arm's length and no promoter/promoter group interest beyond the holding is present.
- · Allana CF Foods Private Limited was incorporated on April 08, 2025.
- · The company's authorised share capital is ₹30,00,00,000 divided into 3,00,00,000 equity shares of ₹10 each.
- · Subscribed and paid-up capital post-allotment is ₹2,87,96,700 divided into 2,87,96,700 equity shares.
- · Turnover of Allana CF Foods is Nil.
- · The transaction is at arm's length basis; promoter/promoter group have no other interest in Allana CF Foods except shares held by Chatha Foods.
02-07-2026
TVS Holdings Limited (formerly Sundaram-Clayton Limited) has subscribed to 6,58,64,009 equity shares of Rs. 10/- each in its subsidiary Home Credit India Finance Private Limited (HCIFPL) for a total cash consideration of Rs. 176.38 Cr (at Rs. 26.78 per share). The additional investment was made via a rights issue to sustain and accelerate HCIFPL's growth, though the company's aggregate holding in HCIFPL remains unchanged at 80.17%. HCIFPL reported a turnover of Rs. 2,112.74 Crore and PAT of Rs. 132.24 Crore for FY 2025-26, showing steady revenue growth over the past three years.
- · HCIFPL is a non-deposit-taking NBFC (middle layer) registered with RBI, operating through POS and online models.
- · The acquisition is a related party transaction as HCIFPL is a subsidiary; promoter group member STPL Trading and Services Private Limited holds 8.08% of HCIFPL.
- · No governmental or regulatory approvals were required for this acquisition.
- · HCIFPL generated a profit after tax of Rs. 132.24 Crore and had a net-worth of Rs. 2,654.35 Crore in FY 2025-26.
02-07-2026
SEBI has issued a Release Order for Recovery Certificate No. 6514 of 2023 against Sitadevi Arunkumar Tulsiyan in the matter of Excel Castronics Limited, indicating that the recovery proceedings against the individual have been complied with. The order is dated July 2, 2026. No financial amounts or percentage changes are disclosed in the filing.
- · The order is classified under 'Recovery Proceedings' on SEBI's enforcement page.
- · The original Recovery Certificate number is 6514 of 2023.
02-07-2026
SEBI issued a release order for Recovery Certificate No. 6285 of 2023 against Mr. Ashi Arunkumar Tulsian in the matter of Excel Castronics Limited, indicating compliance with recovery proceedings. No financial amounts or quantitative data are disclosed.
- · Recovery Certificate No. 6285 of 2023 is referenced.
- · The order is dated July 02, 2026.
- · The filing is categorized under SEBI's Recovery Proceedings.
02-07-2026
SEBI issued a compliance release order for Recovery Certificate No. 6284 of 2025 against Ashi Texfab Pvt Ltd in the matter of Excel Castronics Limited. The order, dated July 2, 2026, pertains to recovery proceedings and indicates that the entity has satisfied the compliance requirements. No financial figures or performance metrics are disclosed in this filing.
- · Recovery Certificate No. 6284 of 2025 was issued against Ashi Texfab Pvt Ltd.
- · The order is a compliance release order, indicating the entity has satisfied the recovery requirements.
- · The matter involves Excel Castronics Limited.
02-07-2026
SEBI issued a compliance release order for Recovery Certificate No. 6273 of 2023 against Kartik Clothing And Fabrics Pvt. Ltd. in the matter of Excel Castronics Limited. The order indicates that the recovery proceedings have been resolved or complied with, resulting in the release of the certificate. No financial penalties or amounts were disclosed in the filing.
- · Recovery Certificate No. 6273 of 2023 has been released by SEBI.
- · The order is categorized under 'Recovery Proceedings' by SEBI.
02-07-2026
SEBI issued a compliance release order for Recovery Certificate No. 6272 of 2023 against Mr. Arun Jwalaprasad Tulsian in the matter of Excel Castronics Limited. The order indicates that the recovery proceedings have been resolved or satisfied, leading to the release. No financial penalties or amounts are specified in the filing.
- · Recovery Certificate No. 6272 of 2023 was issued in 2023.
- · The release order was issued on July 02, 2026.
- · The matter involves Excel Castronics Limited.
02-07-2026
SEBI issued a release order for Recovery Certificate No. 5741 of 2022 against Prabhaben Gordhandas Savjani in the matter of Excel Castronics Limited, indicating compliance with recovery proceedings. The filing does not disclose any financial figures or operational metrics, and no period-over-period comparisons are available.
- · Recovery Certificate No. 5741 of 2022 was issued in the matter of Excel Castronics Limited.
- · The order is a release order for compliance, dated July 02, 2026.
02-07-2026
SEBI has issued a cancellation order for Recovery Certificate No. 5741 of 2022 against Prabhaben Gordhandas Savjani in the matter of Excel Castronics Limited, indicating compliance with a prior enforcement action. The order, dated July 2, 2026, effectively closes the recovery proceedings against the individual. No financial amounts or operational metrics are disclosed in this filing.
- · The cancellation order pertains to Recovery Certificate No. 5741 of 2022.
- · The filing is categorized under SEBI's Recovery Proceedings enforcement section.
- · No financial penalties, settlements, or monetary amounts are mentioned in the order.
02-07-2026
SEBI issued a cancellation order for Recovery Certificate No. 6514 of 2023 against Sitadevi Arunkumar Tulsiyan in the matter of Excel Castronics Limited, indicating compliance with a prior order. The cancellation suggests resolution of the recovery proceedings.
- · Recovery Certificate No. 6514 of 2023 has been cancelled.
- · The order is dated July 02, 2026.
- · The matter involves Excel Castronics Limited.
02-07-2026
SEBI issued a compliance order canceling Recovery Certificate No. 6285 of 2023 against Mr. Ashi Arunkumar Tulsian in the matter of Excel Castronics Limited. The cancellation indicates that the recovery proceedings related to this certificate have been terminated, potentially due to compliance or settlement. No financial figures or operational impact are disclosed.
02-07-2026
SEBI issued a cancellation order for Recovery Certificate No. 6284 of 2023 against Ashi Texfab Pvt. Ltd. in the matter of Excel Castronics Limited, indicating compliance with recovery proceedings. The order effectively cancels the recovery certificate, suggesting resolution or withdrawal of the recovery action.
- · Recovery Certificate No. 6284 of 2023 was cancelled.
- · The order is dated July 02, 2026.
- · The matter involves Excel Castronics Limited.
02-07-2026
SEBI issued a compliance order cancelling Recovery Certificate No. 6273 of 2023 against Kartik Clothing And Fabrics Pvt. Ltd. in the matter of Excel Castronics Limited. The order, dated July 02, 2026, resolves recovery proceedings previously initiated by SEBI against the entity. No financial amounts or quantitative details are disclosed in the filing.
- · Recovery Certificate No. 6273 was issued in 2023 in the matter of Excel Castronics Limited.
- · The cancellation order was for compliance with SEBI's recovery proceedings against Kartik Clothing And Fabrics Pvt. Ltd.
- · The filing type is a Fraud Investigation, but no findings, penalties, or financial details are provided.
02-07-2026
SEBI issued a cancellation order for Recovery Certificate No. 6272 of 2023 against Mr. Arun Jwalaprasad Tulsian in the matter of Excel Castronics Limited, indicating compliance with recovery proceedings. The order cancels a previously issued recovery certificate.
- · Recovery Certificate No. 6272 of 2023 has been cancelled.
- · The order is related to compliance in the matter of Excel Castronics Limited.
02-07-2026
GSP Crop Science Ltd's Board approved a Scheme of Arrangement on July 2, 2026, to amalgamate its wholly owned subsidiary Rajdhani Petrochemicals Private Limited (RPPL) and demerge the manufacturing undertaking of another wholly owned subsidiary, GSP Intermediates Private Limited (GIPL), into itself. The restructuring involves no cash consideration or issuance of new shares, as GSP holds 100% equity in both entities. The move aims to streamline corporate structure, consolidate operations, and achieve cost savings, with no change in the listed entity's shareholding pattern.
- · The appointed date of the Scheme is April 1, 2026.
- · The entire share capital of RPPL and GIPL is held by GSP Crop Science Ltd; no equity shares or other securities will be allotted in exchange.
- · Equity shares held by GSP in RPPL will stand cancelled on the Effective Date.
- · The transaction is a related party transaction (wholly owned subsidiaries) but is exempt from compliance under Section 188 of the Companies Act, 2013 and SEBI Listing Regulations.
- · The demerged undertaking of GIPL had a turnover of ₹2825.94 Lakh for FY 2025-26.
- · The Board meeting commenced at 4:00 PM and concluded at 5:30 PM (IST) on July 2, 2026.
02-07-2026
RenovoRx, Inc. (RNXT) received a second 180-day extension from Nasdaq, until December 28, 2026, to regain compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company failed to meet the original compliance deadline of June 30, 2026, and must now maintain a closing bid price of at least $1.00 for 10 consecutive business days during the Second Compliance Period.
- · Original deficiency notice received December 31, 2025, with first compliance deadline of June 30, 2026.
- · If not compliant by December 28, 2026, Nasdaq will issue a delisting notice; the company may appeal to a Hearings Panel.
- · Company is an emerging growth company and has not elected to use the extended transition period for new accounting standards.
02-07-2026
The Hon'ble NCLT Mumbai Bench has sanctioned the Scheme of Amalgamation of Jaypore E-Commerce Private Limited and TG Apparel & Decor Private Limited (both wholly owned subsidiaries) into Aditya Birla Fashion and Retail Limited (ABFRL) with an appointed date of April 1, 2026. The scheme aims to simplify the legal and operating structure, streamline business and administrative operations, and enhance financial strength and flexibility for ABFRL. No financial consideration is involved as the amalgamating companies are wholly owned subsidiaries, and all shares held by ABFRL in these entities will be cancelled.
- · The appointed date for the scheme is April 1, 2026.
- · Jaypore E-Commerce Private Limited (incorporated February 21, 2012) is a wholly owned subsidiary of ABFRL and is engaged in dealing in linen, readymade garments, textiles, coated fabrics, jewellery, accessories, and marketplace/business support services.
- · TG Apparel & Decor Private Limited (incorporated December 19, 2015) is a wholly owned subsidiary of ABFRL and is currently not carrying any business activity.
- · The Board of Directors of all three companies approved the scheme in their respective meetings held on February 5, 2026.
- · The NCLT dispensed with the requirement of convening meetings of equity shareholders, secured creditors, and unsecured creditors of the amalgamating companies (wholly owned subsidiaries) and of ABFRL, subject to notice being served to ABFRL's secured and unsecured creditors with outstanding balances of ₹25,00,000 or more.
- · The Official Liquidator reported that the affairs of the amalgamating companies were not conducted in a manner prejudicial to public interest or the interest of creditors.
- · An outstanding GST demand against TG Apparel & Decor Private Limited was addressed; the petitioners stated the tax liability had been discharged and an appeal is being preferred, and the scheme preserves all pending legal proceedings.
- · The scheme is exempt from obtaining a No Objection Certificate from stock exchanges under SEBI (LODR) Regulations, 2015 as it involves a holding company and its wholly owned subsidiaries.
02-07-2026
Primo Chemicals Limited's Board approved the acquisition of the remaining 51% equity stake in Flow Tech Chemicals Private Limited for a cash consideration of ₹1,418.20 per share, making it a wholly owned subsidiary by March 31, 2027. The acquisition is a related party transaction and is subject to shareholder approval via postal ballot. Flow Tech has shown strong revenue growth of 24.2% in FY26 to ₹34,166.14 lakh, but its PAT of ₹979.58 lakh, while up significantly from ₹254.58 lakh in FY25, remains modest relative to revenue.
- · The acquisition is a related party transaction as Flow Tech is part of the promoter group and an associate company.
- · Primo has leased 3 acres of land to Flow Tech for 30 years from June 16, 2012 at an annual rent of ₹50,000, renewable for another 30 years.
- · The Board also approved a postal ballot notice for appointment of two independent directors and remuneration for the Managing Director and Executive Director.
- · E-voting period runs from July 7, 2026 to August 5, 2026 with a cut-off date of July 3, 2026.
- · Flow Tech was originally incorporated as Advance Rexine Private Limited on May 16, 1996 and changed its name to Flow Tech Chemicals Private Limited on June 14, 2012.
02-07-2026
BLS E-Services Limited has completed the acquisition of 100% equity shareholding in Atyati Technologies Private Limited (ATPL) for a cash consideration of Rs. 156.82 crore, making ATPL a wholly-owned subsidiary. ATPL, a technology and business correspondent (BC) organization with a presence across 1 lac villages, reported revenue from operations of Rs. 375.8 Crore for FY 2025-26, a decline from Rs. 395.6 Crore in FY 2024-25 and Rs. 389.9 Crore in FY 2023-24. The acquisition aims to expand and consolidate BLS's BC business and strengthen its position in financial inclusion.
- · ATPL was incorporated on March 29, 2006 and is headquartered in Bangalore.
- · ATPL operates across Financial Inclusion, Lending to micro-customers, and technology solutions.
- · The acquisition was completed on July 02, 2026, following prior announcements on February 16, 2026, March 31, 2026, April 30, 2026, and May 18, 2026.
- · The acquisition is not a related party transaction.
02-07-2026
Sandhar Technologies Limited has executed a Share Subscription and Shareholder’s Agreement (SSSHA) to acquire a minimum 26% equity stake in Clean Renewable Energy HR 1B Private Limited (SPV) for a cash consideration of INR 162.52 Lakhs. The acquisition aims to enable the company to avail solar power, reduce energy costs, and meet customer demand for sustainable practices, while the SPV has nil turnover for FY 2025-26 and was incorporated only in June 2025.
- · The SPV, Clean Renewable Energy HR 1B Private Limited, was incorporated on 09th June 2025 and has nil turnover for FY 2025-26.
- · The acquisition is not a related party transaction and is done at arm's length.
- · The indicative time period for completion of the acquisition is 2 months from the date of execution of the SSSHA (i.e., by early September 2026).
- · The acquisition is in the renewable energy/power sector, outside Sandhar's main line of business (auto components).
02-07-2026
BLS International Services Limited announced that its listed subsidiary, BLS E-Services Limited, has acquired 100% equity share capital of Atyati Technologies Private Limited (ATPL) for a cash consideration of Rs. 156.82 crore, effective July 02, 2026. ATPL, an AI-powered banking technology and business correspondent (BC) service provider, reported a revenue of Rs. 375.8 Crore for FY 2025-26, a decline from Rs. 395.6 Crore in FY 2024-25 and Rs. 389.9 Crore in FY 2023-24. The acquisition aims to expand BLS's BC business and strengthen its position in the financial inclusion sector.
- · ATPL was incorporated on March 29, 2006 and is headquartered in Bangalore.
- · The acquisition is a cash consideration deal; no share swap or other consideration involved.
- · No governmental or regulatory approvals were required for the acquisition.
- · The acquisition is not a related party transaction.
- · ATPL's revenue declined from Rs. 395.6 Crore in FY 2024-25 to Rs. 375.8 Crore in FY 2025-26, a decrease of approximately 5%.
02-07-2026
AIP Alternative Lending Fund A filed a final amendment to its tender offer, reporting that it accepted $301.4M in validly tendered shares as of the January 30, 2026 notice date. The fund paid $76.3M (over 25% of the tendered amount's NAV) via promissory notes on April 28, 2026, with the NAV calculated as of March 31, 2026. The offer expired on March 23, 2026, and no withdrawals were made after that date.
- · The tender offer was for up to 5% of the fund's net assets.
- · Shareholders could tender shares by January 30, 2026 (Notice Date) and withdraw until March 23, 2026 (Expiration Date).
- · The NAV for the tendered shares was calculated as of March 31, 2026 (Valuation Date).
- · Payment was made via promissory notes issued on March 23, 2026, with cash payment on or about April 28, 2026.
- · The filing is a final amendment (Amendment No. 2) reporting the results of the tender offer.
02-07-2026
NDL Ventures Limited has convened a meeting of equity shareholders on July 30, 2026, as directed by the National Company Law Tribunal (NCLT), Mumbai Bench, via its order dated June 17, 2026. The meeting will be held through video conferencing/other audio-visual means, with remote e-voting from July 27 to July 29, 2026. The filing includes newspaper advertisements published on July 2, 2026, in The Financial Express (English) and Loksatta (Marathi), detailing the NCLT-convened meeting and e-voting procedures.
- · NCLT order date: June 17, 2026
- · Meeting date: Thursday, July 30, 2026 at 12:00 p.m. (noon) IST
- · E-voting start: 9:00 a.m. IST, Monday, July 27, 2026
- · E-voting end: 5:00 p.m. IST, Wednesday, July 29, 2026
- · Cut-off date for e-voting: Thursday, July 23, 2026
- · Notice of meeting sent to shareholders by email on July 01, 2026
- · Newspaper advertisements published on July 02, 2026
02-07-2026
Dr. Agarwal's Health Care Limited held an NCLT-convened meeting of equity shareholders on July 02, 2026, to approve the Scheme of Amalgamation of Dr. Agarwal's Eye Hospital Limited with the company. The meeting was attended by 47 shareholders (17 promoters, 30 public) out of 43,122 total shareholders. The resolution was passed with the requisite special majority, and the voting results are pending consolidation.
- · Meeting held at The Music Academy, T.T.K. Road, Chennai – 600 014.
- · Meeting duration: 12:30 PM to 1:15 PM IST.
- · Resolution required special majority as per Section 230(6) of Companies Act, 2013.
- · Remote e-voting was available; voting at venue included e-voting and polling papers for proxy holders.
- · Consolidated voting report to be submitted by Scrutinizer.
02-07-2026
Dr. Agarwal's Eye Hospital Limited held a meeting of equity shareholders on July 2, 2026, convened by the NCLT Chennai Bench, to consider and approve a Scheme of Amalgamation with Dr. Agarwal's Health Care Limited. The meeting was attended by 556 shareholders (4 promoters, 552 public) out of a total of 23,610 shareholders, and the resolution was passed with the requisite majority. The filing does not provide financial figures or performance metrics, only procedural details of the shareholder vote.
- · The meeting was held at The Music Academy, T.T.K. Road, Chennai.
- · The NCLT order was dated May 5, 2026 (Company Application No. CA(CAA)/19/CHE/2026).
- · The resolution required special majority as per Section 230(6) of the Companies Act, 2013.
- · Voting was conducted through e-voting at the venue and polling papers for proxy holders.
- · The meeting lasted 45 minutes (9:00 AM to 9:45 AM IST).
02-07-2026
Bharat Petroleum Corporation Ltd. (BPCL) announced that its indirect wholly owned subsidiary, BPRL Ventures BV, has increased its shareholding in IBV Brasil Petroleo Limitada (IBV) from 60.86% to 100% for a cash consideration of Rs. 2,312 Crore. The acquisition, completed on July 1, 2026, provides BPCL with additional equity oil and gas from IBV's concessions in Brazil, contributing to India's energy security. The target entity has had nil turnover for the calendar years 2023, 2024, and 2025.
- · IBV holds participating interests in oil and gas concessions in Brazil.
- · IBV was incorporated on December 26, 2005.
- · Turnover of IBV was nil for calendar years 2023, 2024, and 2025.
- · Concurrence from DIPAM and NITI Aayog was received for the acquisition.
- · The transaction is not a related party transaction.
02-07-2026
Inventurus Knowledge Solutions Limited updated its disclosure regarding the acquisition of TruBridge, Inc. via its wholly-owned subsidiary IKS Inc., reducing the proposed financing facilities from up to USD 670,000,000 to up to USD 635,000,000. The Board also approved additional security interests, including a pledge over shares of Healthcare Resource Group, Inc. (HRG Inc.), a guarantee by HRG Inc., and security over inter-company debts, all subject to shareholder approval. The acquisition and related financing remain on track, with the reduction in facility size indicating a more conservative capital structure.
- · The Board meeting commenced at 6:05 p.m. IST and concluded at 6:26 p.m. IST on July 2, 2026.
- · HRG Inc. will become a material subsidiary of the Company upon consummation of the acquisition.
- · Additional security includes a pledge over the entire ownership interest of Target in HRG Inc., a corporate guarantee by HRG Inc., and security over inter-company debts from IKS Inc., IKS Cares Foundation, and Arai Solutions Private Limited.
- · Non-disposal undertakings were approved for shares of Aquity Solutions India Private Limited and TruBridge Healthcare Private Limited.
02-07-2026
Everflow Eastern Partners, L.P. announced the final results of its issuer tender offer to purchase up to 461,065 units at $1.35 per unit. The company accepted 51,346 units (11.1% of the maximum) for an aggregate of $69,317.10, well below the offer cap. Following the purchase, 4,559,300 units remain outstanding, indicating limited shareholder participation despite the cash tender.
- · The tender offer expired on June 30, 2026, with results reported in this final amendment.
- · Only 51,346 units were tendered out of an available 461,065, reflecting weak holder appetite.
- · Total cash outlay for the buyback was only $69,317.10.
02-07-2026
Dr. Agarwal’s Eye Hospital Limited announced that its shareholders have approved the scheme of amalgamation with Dr. Agarwal’s Health Care Limited, as directed by the NCLT. While the resolution passed with 89.87% votes in favour overall, the public shareholders were sharply divided with 48.10% votes against the scheme, indicating significant minority opposition. The scheme will now proceed for final sanction by the NCLT.
02-07-2026
Dr. Agarwal's Health Care Limited announced that its equity shareholders have approved the Scheme of Amalgamation with Dr. Agarwal's Eye Hospital Limited at an NCLT-convened meeting held on July 2, 2026. The resolution received overwhelming support with 99.97% of votes cast in favor, including unanimous support from the promoter group (100%) and near-unanimous support from public shareholders (99.96%). The scheme is now deemed passed as of July 2, 2026.
- · The NCLT convened meeting was held physically at The Music Academy, T.T.K. Road, Chennai.
- · The e-voting period ran from June 7, 2026 to July 1, 2026.
- · The record date for voting eligibility was June 3, 2026.
- · No promoter/promoter group was deemed interested in the resolution except to the extent of shareholding/common directorships.
- · Total outstanding shares of the company were 316,983,028.
02-07-2026
Dr. Agarwal's Eye Hospital Limited held a meeting of its sole secured creditor on July 2, 2026, to approve a Scheme of Amalgamation with Dr. Agarwal's Health Care Limited. The resolution was passed with the requisite special majority, as the single secured creditor present voted in favor. The meeting, convened by order of the NCLT Chennai Bench, concluded in 15 minutes with full creditor approval.
- · The meeting was held at The Music Academy, T.T.K. Road, Chennai – 600 014.
- · The meeting lasted from 10:30 A.M. to 10:45 A.M. IST (15 minutes).
- · Voting was conducted through e-voting at the venue and by polling paper for valid proxy holders.
- · The resolution was a special majority resolution under Section 230(6) of the Companies Act, 2013.
02-07-2026
Dr. Agarwal's Health Care Limited held a meeting of its secured creditors on July 2, 2026, convened by the NCLT Chennai Bench, to consider and approve a Scheme of Amalgamation of Dr. Agarwal's Eye Hospital Limited with the company. The meeting had only 2 out of 3 secured creditors present, but the quorum of 1 was met, and the resolution was duly transacted. The filing confirms procedural compliance but does not disclose the voting outcome or any dissent, leaving the scheme's approval status unclear.
- · The meeting was held at The Music Academy, T.T.K. Road, Chennai on July 2, 2026 at 3:00 PM IST.
- · The NCLT order convening the meeting was dated May 5, 2026 (Company Application No. CA(CAA)/19/CHE/2026).
- · The resolution required a special majority as prescribed under section 230(6) of the Companies Act, 2013.
- · Voting was conducted through e-voting at the venue and polling paper for proxy holders; remote e-voting was kept open during the meeting.
- · The meeting concluded at 3:15 PM IST, lasting only 15 minutes.
02-07-2026
Dr. Agarwal's Health Care Limited announced that secured creditors have approved the scheme of amalgamation between Dr. Agarwal's Eye Hospital Limited and the company, as per the consolidated scrutinizer's report dated July 2, 2026. The meeting convened by NCLT resulted in the resolutions being passed by the requisite majority, with no mention of dissent or rejection.
- · The meeting was held at The Music Academy, T.T.K. Road, Chennai on July 2, 2026 at 3:00 PM IST.
- · The NCLT Order appointing Shri Shivam Parashar as Scrutinizer was dated May 5, 2026.
- · Facilities provided included remote e-voting, e-voting at the venue, and voting via polls.
- · The resolutions were deemed passed as on July 2, 2026.
02-07-2026
Dr. Agarwal's Eye Hospital Limited announced that its secured creditors have approved the Scheme of Amalgamation with Dr. Agarwal's Health Care Limited at a meeting convened by the NCLT on July 2, 2026. The resolution was passed with the requisite majority, and the scheme is now subject to final sanction by the NCLT. No financial figures or voting percentages were disclosed in the filing.
- · The NCLT convened meeting was held on July 2, 2026, at The Music Academy, Chennai.
- · The remote e-voting period ran from June 7, 2026, to July 1, 2026.
- · The cut-off date for voting eligibility was December 31, 2025.
- · The requisite quorum of 1 secured creditor was present at the meeting.
- · The scheme is between Dr. Agarwal's Eye Hospital Limited (transferor) and Dr. Agarwal's Health Care Limited (transferee).
02-07-2026
Dr. Agarwal's Eye Hospital Limited held an NCLT-convened meeting of unsecured creditors on July 02, 2026, to consider and approve the Scheme of Amalgamation with Dr. Agarwal's Health Care Limited. The meeting, chaired by Shri Kanwal Jeet Arora, achieved the required quorum of 30 unsecured creditors out of a total of 371, and the resolution was passed by special majority. The results of voting are pending the Scrutinizer's consolidated report.
- · The meeting was held at The Music Academy, T.T.K. Road, Chennai – 600 014.
- · The NCLT order date for convening the meeting was May 05, 2026.
- · The record date for unsecured creditors was Wednesday, December 31, 2025.
- · The required quorum was 30 unsecured creditors as prescribed by the NCLT.
- · Voting was conducted through e-voting at the venue and polling papers for proxy holders.
- · The meeting started at 11:30 A.M. (IST) and concluded at 12:05 P.M. (IST).
Get daily alerts with 11 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Global High-Priority Regulatory Events
🇺🇸 More from United States
View all →June 25, 2026
US Pre-Market SEC Filings Roundup — June 25, 2026
US Pre-Market SEC Filings Roundup
June 25, 2026
S&P 500 Healthcare Sector SEC Filings — June 25, 2026
S&P 500 Healthcare Sector SEC Filings
June 25, 2026
US IPO Pipeline SEC S-1 Filings — June 25, 2026
US IPO Pipeline SEC S-1 Filings
June 25, 2026
US Merger & Acquisition SEC Filings — June 25, 2026
US Merger & Acquisition SEC Filings